Q3 EPS Forecast for Benitec Biopharma Increased by Analyst
Benitec Biopharma Inc. (NASDAQ:BNTC – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2025 earnings per share estimates for Benitec Biopharma in a research report issued on Monday, March 31st. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will earn ($0.26) per share for the quarter, up from […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Free Report) – Equities research analysts at Leerink Partnrs raised their Q3 2025 earnings per share estimates for Benitec Biopharma in a research report issued on Monday, March 31st. Leerink Partnrs analyst M. Foroohar now anticipates that the biotechnology company will earn ($0.26) per share for the quarter, up from […]
